Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Mol Cancer Ther April 1 2011 10 (4) 567-567;

Review

  • Review
    Targeting Oncogenic ALK: A Promising Strategy for Cancer Treatment
    Enrique Grande, María-Victoria Bolós and Edurne Arriola
    Mol Cancer Ther April 1 2011 10 (4) 569-579; DOI:10.1158/1535-7163.MCT-10-0615

Therapeutic Discovery

  • Therapeutic Discovery
    GPR54 Is a Target for Suppression of Metastasis in Endometrial Cancer
    Hyun Sook Kang, Tsukasa Baba, Masaki Mandai, Noriomi Matsumura, Junzo Hamanishi, Budiman Kharma, Eiji Kondoh, Yumiko Yoshioka, Shinya Oishi, Nobutaka Fujii, Susan K. Murphy and Ikuo Konishi
    Mol Cancer Ther April 1 2011 10 (4) 580-590; DOI:10.1158/1535-7163.MCT-10-0763

  • Therapeutic Discovery | Free Article
    Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
    Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer, Marc Labroli, Frances Shanahan, Nicole Davis, Lorena Taricani, Derek Wiswell, Wolfgang Seghezzi, Ervin Penaflor, Bhagyashree Bhagwat, Wei Wang, Danling Gu, Yunsheng Hsieh, Suining Lee, Ming Liu and David Parry
    Mol Cancer Ther April 1 2011 10 (4) 591-602; DOI:10.1158/1535-7163.MCT-10-0928

  • Therapeutic Discovery
    Targeted Delivery of an Antibody–Mutant Human Endostatin Fusion Protein Results in Enhanced Antitumor Efficacy
    Seung-Uon Shin, Hyun-Mi Cho, Jaime Merchan, Jin Zhang, Krisztina Kovacs, Yawu Jing, Sundaram Ramakrishnan and Joseph D. Rosenblatt
    Mol Cancer Ther April 1 2011 10 (4) 603-614; DOI:10.1158/1535-7163.MCT-10-0804

  • Therapeutic Discovery
    Novel Functions for mda-7/IL-24 and IL-24 delE5: Regulation of Differentiation of Acute Myeloid Leukemic Cells
    Bin-Xia Yang, Yong-Juan Duan, Cheng-Ya Dong, Fang Zhang, Wei-Feng Gao, Xue-Ying Cui, Yong-Min Lin and Xiao-Tong Ma
    Mol Cancer Ther April 1 2011 10 (4) 615-625; DOI:10.1158/1535-7163.MCT-10-0863

  • Therapeutic Discovery
    Targeting Ovarian Tumor Cell Adhesion Mediated by Tissue Transglutaminase
    May Khanna, Bhadrani Chelladurai, Aruna Gavini, Liwei Li, Minghai Shao, David Courtney, John J. Turchi, Daniela Matei and Samy Meroueh
    Mol Cancer Ther April 1 2011 10 (4) 626-636; DOI:10.1158/1535-7163.MCT-10-0912

  • Therapeutic Discovery
    Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
    Yuh-Pyng Sher, Shih-Jen Liu, Chun-Mien Chang, Shu-Pei Lien, Chien-Hua Chen, Zhenbo Han, Long-Yuan Li, Jin-Shing Chen, Cheng-Wen Wu and Mien-Chie Hung
    Mol Cancer Ther April 1 2011 10 (4) 637-647; DOI:10.1158/1535-7163.MCT-10-0827

  • Therapeutic Discovery
    Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer
    Holly Symolon, Anatoliy Bushnev, Qiong Peng, Harsha Ramaraju, Suzanne G. Mays, Jeremy C. Allegood, Sarah T. Pruett, M. Cameron Sullards, Dirck L. Dillehay, Dennis C. Liotta and Alfred H. Merrill Jr.
    Mol Cancer Ther April 1 2011 10 (4) 648-657; DOI:10.1158/1535-7163.MCT-10-0754

  • Therapeutic Discovery
    Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases
    Jie Yang, Donna McEachern, Wenyan Li, Mary A. Davis, Hua Li, Meredith A. Morgan, Longchuan Bai, Jonathan T. Sebolt, Haiying Sun, Theodore S. Lawrence, Shaomeng Wang and Yi Sun
    Mol Cancer Ther April 1 2011 10 (4) 658-669; DOI:10.1158/1535-7163.MCT-10-0643

Preclinical Development

  • Preclinical Development
    Context Dependence of Checkpoint Kinase 1 as a Therapeutic Target for Pancreatic Cancers Deficient in the BRCA2 Tumor Suppressor
    Hiroyoshi Hattori, Ferdinandos Skoulidis, Paul Russell and Ashok R. Venkitaraman
    Mol Cancer Ther April 1 2011 10 (4) 670-678; DOI:10.1158/1535-7163.MCT-10-0781

  • Preclinical Development
    Rapamycin Reverses Splenomegaly and Inhibits Tumor Development in a Transgenic Model of Epstein-Barr Virus–Related Burkitt's Lymphoma
    Osman Cen and Richard Longnecker
    Mol Cancer Ther April 1 2011 10 (4) 679-686; DOI:10.1158/1535-7163.MCT-10-0833

Molecular Medicine in Practice

  • Molecular Medicine in Practice
    Gene Expression Profiling Provides Insights into Pathways of Oxaliplatin-Related Sinusoidal Obstruction Syndrome in Humans
    Laura Rubbia-Brandt, Sébastien Tauzin, Catherine Brezault, Céline Delucinge-Vivier, Patrick Descombes, Bertand Dousset, Pietro E. Majno, Gilles Mentha and Benoit Terris
    Mol Cancer Ther April 1 2011 10 (4) 687-696; DOI:10.1158/1535-7163.MCT-10-1072

  • Molecular Medicine in Practice
    Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma
    Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Beverly S. Schaffer, Eri Taniguchi, Aoife Kilcoyne, Amanda T. McCleish, Laura D. Nelon, Francis G. Giles, Argiris Efstratiadis, Robin D. LeGallo, Brent M. Nowak, Brian P. Rubin, Suman Malempati and Charles Keller
    Mol Cancer Ther April 1 2011 10 (4) 697-707; DOI:10.1158/1535-7163.MCT-10-0695

Correction

  • Correction
    Correction: Interstitial Infusion of Glioma-Targeted Recombinant Immunotoxin 8H9scFv-PE38
    Mol Cancer Ther April 1 2011 10 (4) 708-708; DOI:10.1158/1535-7163.MCT-11-0092

Back to top
PreviousNext
Molecular Cancer Therapeutics: 10 (4)
April 2011
Volume 10, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Jump to

  • Highlights
  • Review
  • Therapeutic Discovery
  • Preclinical Development
  • Molecular Medicine in Practice
  • Correction
Advertisement
  • Most Cited
  • Most Read
Loading
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • Truncated BRCA2 Contributes to PARPi Resistance
  • ERPAS to Predict Response to Endocrine Therapy
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Sialoglycan mAb for Cancer Immunotherapy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement